scholarly journals The Impact of Sub-valvular Apparatus Preservation on Prosthetic Valve Dysfunction During Mitral Valve Replacement

2012 ◽  
Vol 1 (2) ◽  
pp. 55-61 ◽  
Author(s):  
Alireza Alizadeh-Ghavidel ◽  
Yalda Mirmesdagh ◽  
Mehrzad Sharifi ◽  
Anita Sadeghpour ◽  
Reza Nakhaeizadeh ◽  
...  

2016 ◽  
Vol 55 (5) ◽  
pp. 479-483 ◽  
Author(s):  
Tetsuro Yokokawa ◽  
Takahiro Ohara ◽  
Seiji Takashio ◽  
Mari Sakamoto ◽  
Yuko Wada ◽  
...  


Author(s):  
Ahmet Güner ◽  
Ersin Kadiroğulları ◽  
Taner İyigün ◽  
İsmail Gürbak ◽  
Burak Onan ◽  
...  

Objectives: Redo mitral valve replacement (redo-MVR) represents a clinical challenge due to a higher rates of peri-operative morbidity and mortality. Patients and Methods: This retrospective study enrolled a total of 103 patients who underwent isolated redo-MVR due to prosthetic valve dysfunction. Patients who had an isolated bypass, low echocardiographic quality, history of repeated re-replacements (more than twice), paravalvular leak repair without preoperative and intraoperative transesophageal echocardiography examination, isolated congenital surgery or isolated open-heart surgical intervention (of any type) without a valve procedure at their first or later operations were excluded. The primary endpoint of the study was in-hospital death. Secondary endpoint included individual morbidity. Results: A total of 103 patients (mean age: 50.7 13.4 years; male: 58) who underwent isolated redo-MVR were enrolled in this study. The most common complaint of the patients at admission was obstruction or heart failure-related symptoms (80.6%) and the primary indication for redo-MVR was prosthetic valve thrombosis in 58 patients (56.3%). In-hospital mortality was 12.6% (13 patients). The post-operative complications included major bleeding (n=11) post-operative infection (sepsis, mediastinitis, pneumonia, wound infection, n=15), low cardiac output syndrome (n=10), acute kidney injury (n=17), pericardial effusion with tamponade (n=10), pleural effusion requiring hospitalization and drainage (n=18), ischemic stroke (n=4), fatal ventricular arrhythmia (n=1), peripheral embolism (n=1), moderate to severe paravalvular leak (n=5). There was not any catastrophic heart laceration. Conclusion: In-hospital mortality and complications of the isolated redo-MVR in our center are acceptable. With a well-defined protocol and appropriate patient selection, mortality in emergencies cases may be reduced.





1995 ◽  
Vol 59 (1) ◽  
pp. 187-189 ◽  
Author(s):  
Yutaka Okita ◽  
Shigehito Miki ◽  
Yuichi Ueda ◽  
Takafumi Tahata ◽  
Tetsuro Sakai ◽  
...  


2019 ◽  
Vol 87 (5) ◽  
pp. 380-382
Author(s):  
Juan R. Alderete ◽  
Alberto C. Anaya Revolledo ◽  
Verónica I. Volberg ◽  
Miguel Rubio ◽  
Gustavo E. Barrera ◽  
...  


2021 ◽  
Author(s):  
Hon Chun ◽  
Bo Mei ◽  
Guang-xian Chen ◽  
Kang-ni Feng ◽  
Meng-ya Liang ◽  
...  

Abstract Background The mitral valve shows significant involvement in hypertrophic obstructive cardiomyopathy (HOCM). The mid-term outcomes of management of HOCM by prosthetic valve replacement with septal myectomy remain unclear. This study compared the prognosis of patients with and without prosthetic valve replacement. Methods From 01/2009 until 10/2015, 24 patients with HOCM underwent septal myectomy with or without valve repair/replacement were recruited. A total of 23 patients underwent echocardiographic evaluation before and after the operation. The follow-up duration ranged from 0.4 to 7 years (median 2.5 years). The Kaplan-Meier test was used to explore the association between prosthetic valve replacement and overall/disease-free survival among HOCM patients. Results A total of 9 patients underwent septal myectomy with/without mitral valve repair (MVr), and the other 15 patients underwent septal myectomy with mitral valve replacement (MVR). Six patients treated with MVR had unfavorable outcomes, including one peri-operative and three late deaths; one patient suffered from aborted sudden death, and one patient was treated for prosthetic valve endocarditis. Prosthetic valve replacement was associated with poor disease-free survival (p = 0.025). Conclusions Septal myectomy with or without-MVr was associated with a better outcome than septal myectomy with MVR in HOCM patients. The differences in prognosis were caused by more complicated left ventricular outflow tract structures and more prosthetic valve complications among patients undergoing MVR.



2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Jiang-Shan Huang ◽  
Ning Xu ◽  
Kai-Peng Sun ◽  
Zhi-Nuan Hong ◽  
Liang-Wan Chen ◽  
...  

Abstract Background We want to compare the impact on health-related quality of life (HRQoL) between the Star GK and the SJM valve in the Chinese population. Methods We retrospectively enrolled a total of 172 patients who had undergone mechanical mitral valve replacement (MVR) (SJM valve in 87 patients and Star GK valve in 85 patients) at our institution from January 2013 to December 2015. We measured the sound pressure level, and used 2 self-administered questionnaires and the Chinese version of SF-36 to measure the HRQoL and valve-specific questions to evaluate patient anxiety. Results The Star GK group and the SJM group were similar in age, gender, body surface area, diameter of the implanted valve, underlying disease and current median NYHA class. Regarding the valve sound pressure perceived 1 year after operation, the SJM valve was slightly quieter than the Star GK valve, but the sound pressures of the two valves showed no significant differences. No significant differences in any of the eight subscales of the SF-36 were found between the two groups. Conclusions The present study suggests that the Star GK valve is similar to the SJM valve in its impact on HRQoL and audibility of mechanical sound in the Chinese population.



Sign in / Sign up

Export Citation Format

Share Document